The University of Arizona Health Sciences Center

Dr. Andrew Yeager to Direct UMC Blood and Marrow Transplantation Program

May 4, 2005
From: AHSC Public Affairs, 626-4828


Click on image to enlarge
Andrew M. Yeager, MD, has been named the new director of the Blood and Marrow Transplantation Program at University Medical Center and The Arizona Cancer Center.

Dr. Yeager, who also will serve as a professor of medicine and pediatrics at the University of Arizona College of Medicine, came to Tucson in April from the University of Pittsburgh Cancer Institute, where he was director of the Stem Cell Transplantation Program.

Dr. Yeager received his medical degree from Johns Hopkins University, where he also completed a residency in pediatrics and fellowship training in pediatric hematology/oncology. He then spent 11 years on the faculty at Hopkins, followed by seven years on the faculty at Emory University School of Medicine before moving to Pittsburgh in 2000.

Dr. Yeager is internationally recognized for his studies of stem cell transplantation in adults and children with leukemia and in children with genetic storage diseases or sickle cell anemia.

"It is not just bone marrow transplantation for leukemia anymore. We are seeing more and more versatility in the application of blood stem cell transplantation to diseases outside of hematologic malignancies," Dr. Yeager said.

Much of Dr. Yeager's work at the University of Pittsburgh Cancer Institute will carry over to the Arizona Cancer Center. In Pittsburgh, he was in charge of both clinical and research activities related to blood and marrow transplantation. He oversaw both allogeneic and autologous transplants for a variety of blood diseases, blood cancers and hematologic malignancies.

"The Bone and Marrow Transplant Program here in Tucson is but one part of an incredibly strong and leading National Cancer Institute-designated cancer center. It's a real honor to be part of such a remarkable organization." Dr. Yeager said.

"Above all else, we need to make sure we have a transplant program that is focused on the patient and the patient's family. Of course, we want to be at the cutting- edge for both clinical and laboratory research activities, but the most compassionate, comprehensive care of the patient must always be our top priority," he said.

# # #

Find It/Search Health Information People Find Student Information Homepage